HIV, AIDS and the Immune SystemAIDS, HIV and The Immune SystemIntroductionThe virus responsible for the condition known as AIDS (Acquired Immunodeficiency Syndrome), is named HIV (Human Immunodeficiency Virus). AIDS is the condition whereby the body's specific defense system against all infectious agents no longer functions properly. There is a focused loss over time of immune cell function which allows intrusion by several different infectious agents, the result of which is loss of the ability of the body to fight infection and the subsequent acquisition of diseases such as pneumonia. We will examine the virus itself, the immune system, the specific effect(s) of HIV on the immune system, the research efforts presently being made to investigate this disease, and finally, how one can try to prevent acquiring HIV.The VirusHIV is one member of the group of viruses known as retroviruses. The term "retrovirus" stems from the fact that these kinds of viruses are capable of copying RNA into DNA. No other organism so far discovered on earth is capable of this ability. The virus has two exact copies of single-stranded RNA as its basic genetic material (genome) in the very center of the organism. The genome is surrounded by a spherical core made of various proteins in tightly-packed association with one another. The core is itself surrounded by a membrane (called an "envelope", made of fat [lipids] and various membrane-bound proteins). One of the membrane-boundproteins can bind to a particular protein on the surface of certain immune cells, called T-cells (we'll talk about these in a minute) which results in the virus becoming physically attached. Upon binding, the virus is brought inside of the T-cell (cells do this kind of thing all of the time), and the envelope is removed by enzymes normally present inside the cell. The internal core is thus exposed, and it too is broken-down. This last phase results in exposure of the virus's RNA genetic material. An enzyme attached to the RNA, known as "reverse transcriptase", begins to make a complimentary base-pair single-strand copy of the RNA into DNA (please see What the Heck is PCR? ). The single strand of DNA is also copied by the same enzyme to form double-stranded DNA. This DNA inserts somewhere into one of the 46 chromosomes within our cells, and there it is used as a template for production of all of the things necessary to form new virus particles ( replication of the virus). These new virus particles can be subsequently released from the infected cell, and can infect adjacent cells.The Immune SystemThe immune system is a system within all vertebrates (animals with a backbone) which in general terms, is comprised of two important cell types: the B-cell and the T-cell. The B-cell is responsible for the production of antibodies (proteins which can bind to specific molecular shapes), and the T-cell (two types) is responsible either for helping the B-cell to make antibodies, or for the killing of damaged or "different" cells (all foreign cells except bacteria) within the body. The two main types of T-cells are the "helper"T-cell and the cytotoxic T-cell. The T-helper population is further divided into those which help B-cells (Th2) and those which help cytotoxic T-cells (Th1). Therefore, in order for a B-cell to do its job requires the biochemical help of Th2 helper T-cells; and, for a cytotoxic T-cell to be able to eliminate a damaged cell (say, a virally-infected cell), requires the biochemical help of a Th1 helper T-cell.
Whenever any foreign substance or agent enters our body, the immune system is activated. Both B- and T-cell members respond to the threat, which eventually results in the elimination of the substance or agent from our bodies. If the agent which gains entry is the kind which remains outside of our cells all of the time (extracellular pathogen), or much of the time (virus often released) the "best" response is the production by B-cells of antibodies which circulate all around the body in the bloodstream, and eventually bind to the agent. There are mechanisms available which are very good at destroying anything which has an antibody bound to it. On the other hand, if the agent is one which goes inside one of our cells and remains there most of the time (intracellular pathogens like viruses or certain bacteria which require the inside of one of our cells in order to live), the "best" response is the activation of cytotoxic T-cells (circulate in the bloodstream and lymph), which eliminate the agent through killing of the cell which contains the agent (agent is otherwise "hidden"). Both of these kinds of responses (B-cell or cytotoxic T-cell) of course require specific helper T-cell biochemical information as described above. Usually, both B-cell and cytotoxic T-cell responses occur against intracellular agents which provides a two-pronged attack. Normally, these actions are wonderfully protective of us. The effect of HIV on the immune system is the result of a gradual(usually) elimination of the Th1 and Th2 helper T-cell sub-populations.
The fight between the virus and the immune system for supremacy is continuous. Our body responds to this onslaught through production of more T-cells, some of which mature to become helper T-cells. The virus eventually infects these targets and eliminates them, too. More T-cells are produced; these too become infected, and are killed by the virus. This fight may continue for up to ten years before the body eventually succumbs, apparently because of the inability to any-longer produce T-cells. This loss of helper T-cells finally results in the complete inability of our body to ward-off even the weakest of organisms (all kinds of bacteria and viruses other than HIV) which are normally not ever a problem to us. This acquired condition of immunodeficiency is called, AIDS.
Our immune system's ability to recognize any foreign substance or agent, depends entirely upon how the substance or agent "looks" with respect to the molecular shapes displayed - just as your elbow looks different than someone else's elbow - even though each are clearly elbows. Therefore, while an individual may become infected with a single strain of HIV, over several years of many, many viral generations, an individual may have 10 different strains of HIV present. Further, to date no two people have been identified to have been infected with the same strain of HIV. Consequently, against which strain should a population be immunized? In such cases, one tries to identify molecular shapes which are common to all known strains - in this way, all strains would theoretically be recognizable by our immune system. Sadly, this research has failed to provide an effective vaccine. This virus is subtle, and can do some very covert things using biochemical mechanisms we do not yet understand. Because of recent basic research in the field of immunology (the discipline which develops an understanding of the intricate workings of the immune system), based upon years of previous basic research in this and other fields however, some light is beginning to emerge which may help us.
It is becoming clear that the two helper T-cell types identified only a few years ago may be significantly more important than first assumed. Remember, the Th1 helper-cell helps generate a cytotoxic T-cell response, and the Th2 helper-cell helps generate an antibody response. As it turns out, certain intracellular pathogens primarily elicit a Th2 response in certain in-bred strains of mice, while in a different in-bred mouse strain, the same pathogen primarily elicits a Th1 response. In this example, all mice which respond primarily with antibody (B-cell; Th2 help), die; and, all mice which primarily respond with a cytotoxic T-cell response (Th1 help), live! Such is not the case for every intracellular pathogen - some responses are very balanced with respect to B-cell and cytotoxic T-cell contributions, and others are imbalanced in one or the other direction. The balance in contribution of these two paths to an immune response, appears to not only depend upon the particular infectious organism, but also upon the particular genetic background of the infected animal. Thus, one can imagine that one may be able to find a way to tip the balance towards the most effective response path against a given organism, e.g., either antibody production by B-cells, or development of cytotoxic T-cells. This research is one of the prime areas under investigation with regard to HIV. There are very limited data to date; but, those individuals who have had HIV for a really long time, but have not yet acquired AIDS (there are indeed now a number of such individuals), appear to have their immune response shifted towards the cytotoxic side (Th1 help). This limited information on HIV, in combination with basic research information on several different diseases using animal models (mice), has generated a quick response within the research community. Consequently, there are efforts currently underway to identify the biochemical substances which are involved in directing a response along the Th1 path, and efforts to determine how the immune system might be manipulated to direct a response along a given path. Such experimentation is long and difficult, and requires money, skill, unflinching commitment, and an abiding faith that this problem can be solved.
Under normal circumstances, the design of the immune system's various tissues and connections, allows the agent to be focused within a regional lymph node, which greatly improves the probability of an effective defensive response. In the case of HIV, however, this ability either brings the target cells to the virus, or brings the virus to the target cells. Consequently, the only way to prevent exposure to the virus, is to avoid situations which allow the potential for entry of the virus. Such situations are overwhelmingly associated with sexual intercourse, intravenous drug use, and exposure of a cut in one's skin to the bodily fluids (secretions, blood) of an HIV-infected individual. Such situations do not include hugging, touching, or other nonfluid-exchange expressions of caring for someone infected with HIV.
Oral, vaginal, and anal intercourse can lead to tiny abrasions of the mucosal tissue in these areas; and, within the tissues of the mouth (gums in particular) there will almost always be tiny abrasions present under any circumstances. These openings provide access by the virus to the blood and lymphatic streams, as well as to cells within the tissue. If a person is infected with HIV, there will be virus within the secretions of the person (particularly the seminal fluid of males), and in the blood of the person.Consequently, the direct exposure to bodily fluids (secretions, blood) can potentially occur between both partners (female/female, male/male, female/male) during any kind of sexual intercourse, whether or not ejaculation by a male partner occurs. While the body may be able to ward-off a small amount of virus, repeated exposure to such amounts places a person, particularly women having vaginal intercourse, and men and women having anal intercourse with an HIV-infected partner, at significant risk of HIV infection. Under any circumstance, there is a risk of HIV infection through only one sexual intercourse encounter. The use of a condom for the male partner, in combination with chemical substances which kill viruses, is recommended. Multiple sexual partners, unprotected sexual intercourse, anal sexual intercourse, the presence of other sexually-transmitted disease, and intravenous drug usage significantly increase the risk of HIV infection.
One can be tested for the presence of HIV through an appointment with one's local Health Department (state-supported). Health department test results are completely confidential and inaccesible to anyone but the patient and testing physician at the public-health clinic. While a personal physician's records are also confidential, these records are however, subject to examination at any time by the health insurer(s) of the physician.No matter where one chooses to be examined, one will be required to undergo a pre-test and post-test psychological counseling session.
Recent Statistics (January, 1995): The CDC report showed 401,749 cases of AIDS in the U.S. through the middle of 1994, while approximately one-million within the U.S. are infected with HIV. Twenty percent of all AIDS cases within the U.S. are within the 20s age-group - (apparently contracted HIV while teenagers).
The CDC AIDS Hotlines are:English: 800-342-2437 (800-342-AIDS)Spanish: 800-344-7432 (800-344-SIDA)Deaf: 800-243-7889.Your local Health Department is also a good source of information. Become informed.
Original post:
AIDS, HIV and The Immune System - Single Sign-On | The ...
- Eosinophil innate immune memory after bacterial skin infection promotes allergic lung inflammation - Science | AAAS - April 5th, 2025
- Researchers Discover mRNA Vaccines Leave Lasting Mark on the Immune System - SciTechDaily - April 5th, 2025
- Scientific Journeys: Uncovering how dioxins affect the immune system - National Institutes of Health (NIH) (.gov) - April 5th, 2025
- Oligodendroglial precursor cells modulate immune response and early demyelination in a murine model of multiple sclerosis - Science | AAAS - April 5th, 2025
- Measles can ravage the immune system and brain, causing long-term damage a virologist explains - The Conversation - April 5th, 2025
- Microscopic Instigators - The University of New Mexico - April 5th, 2025
- Changes in the immune index before and after surgery in urinary malignancy patients with AIDS - Nature - April 5th, 2025
- Non-immune targeting of CXCR3 compromises mitochondrial function and suppresses tumor growth in glioblastoma - Nature - April 5th, 2025
- 8 Supplements That Will Boost Your Immune System - Verywell Health - April 5th, 2025
- Improving immunotherapy for the treatment of hepatocellular carcinoma: learning from patients and preclinical models - Nature - April 5th, 2025
- Redefining the immune landscape of hepatitis A virus infection - Nature - April 5th, 2025
- What Happens to Your Immune Health When You Take Vitamin C and Zinc Together? - Verywell Health - April 5th, 2025
- Diet Has A Major Impact On The Immune System - WorldHealth.net - April 5th, 2025
- Top 7 ways to boost your immune system - The Indian Express - April 5th, 2025
- Kinetics of pIgR and IgM immune responses in snakehead ( Channa argus ) to inactivated Aeromonas hydrophila via immersion and intraperitoneal... - April 5th, 2025
- What Is Man Flu? - Cleveland Clinic Health Essentials - April 5th, 2025
- Dynamics of T cell subpopulations and plasma cytokines during the first year of antineoplastic therapy in patients with breast cancer: the BEGYN-1... - April 5th, 2025
- Publication in npj Vaccines Reports Cross-reactive and Long-Lasting Immune Responses for self-amplifying mRNA (samRNA) COVID-19 Vaccine Booster... - April 5th, 2025
- 9 Supplements, Tonics, and Oils to Boost Immune Health - W Magazine - April 5th, 2025
- Preoperative pan-immuno-inflammatory values and albumin-to-globulin ratio predict the prognosis of stage IIII colorectal cancer - Nature - April 5th, 2025
- Systemic Lupus Erythematosus (Lupus) - Who gets it? | NIAMS - February 7th, 2025
- Systemic Lupus Erythematosus (Lupus) Basics - National Institute of ... - February 7th, 2025
- Long COVID: women at greater risk compared to men could immune system differences be the cause? - The Conversation - February 7th, 2025
- What is Pemphigus? Symptoms & Causes | NIAMS - February 7th, 2025
- How the immune system influences pancreatic cancer: New interactions provide therapeutic insights - Medical Xpress - February 7th, 2025
- Mitochondrias Secret Power Unleashed in the Battle Against Inflammation - SciTechDaily - February 7th, 2025
- WNT11 Promotes immune evasion and resistance to Anti-PD-1 therapy in liver metastasis - Nature.com - February 7th, 2025
- The role of the behavioral immune system in the expression of short and long-term orientation in young Chilean men during the COVID-19 pandemic - BMC... - February 7th, 2025
- Harvard nutritionist eats these 5 foods to keep her 'immune system strong' and 'energy high' - CNBC - February 7th, 2025
- Micro Immune Response On-chip (MIRO) models the tumour-stroma interface for immunotherapy testing - Nature.com - February 7th, 2025
- Personalized Therapeutic Vaccine Steers the Immune System to Fight Kidney Cancer | Newswise - Newswise - February 7th, 2025
- Identification of m6A methyltransferase-related WTAP and ZC3H13 predicts immune infiltrates in glioblastoma - Nature.com - February 7th, 2025
- Serotonin attenuates tumor necrosis factor-induced intestinal inflammation by interacting with human mucosal tissue - Nature.com - February 7th, 2025
- Identification of the immune infiltration and biomarkers in ulcerative colitis based on liquidliquid phase separation-related genes - Nature.com - February 7th, 2025
- FLASH radiation reprograms lipid metabolism and macrophage immunity and sensitizes medulloblastoma to CAR-T cell therapy - Nature.com - February 7th, 2025
- Young Innovators: U of S researcher uses bat immune systems to find next generation therapies - Saskatoon Star-Phoenix - February 7th, 2025
- World Cancer Day 2025: Chronic stress, immune system, and cancer risk- How are these connected? - The Times of India - February 7th, 2025
- New research unlocks key to long-lasting immune response in cancer and chronic diseases - The Peter Doherty Institute for Infection and Immunity - February 7th, 2025
- Microbial Dynamics and Immune Response to NTHi in COPD - Physician's Weekly - February 7th, 2025
- MHE Week in Review RFK Jr. Spotlight - Managed Healthcare Executive - February 7th, 2025
- Psoriasis Basics: Overview, Symptoms, and Causes - January 27th, 2025
- Vitiligo Symptoms, Treatment & Causes | NIAMS - January 27th, 2025
- The Surprising Connection Between Obesity, Parasites, and Your Immune System - SciTechDaily - January 27th, 2025
- Versatile 69p spice that boosts immune system can go in soups, smoothies and milk - Express - January 27th, 2025
- How the skins secret immune system could lead to needle-free vaccines - Gavi, the Vaccine Alliance - January 27th, 2025
- Fevers link with a key kind of immunity is surprisingly ancient - Science News Magazine - January 27th, 2025
- Immunology - The Scientist - January 27th, 2025
- Opinion: Immune System And Ageing Why We Get More Vulnerable As We Age - ABP Live - January 27th, 2025
- 'Forever chemicals' (PFAS) may weaken immune function in children, leading to more frequent infections - U.S. Right to Know - January 27th, 2025
- Cellular Signals That Wreak Havoc in Sepsis are Revealed - LabRoots - January 27th, 2025
- New Combination Immunotherapy Targets Melanoma and Breast Cancer with Promising Results - Inside Precision Medicine - January 27th, 2025
- New Research in The Journal of Poultry Science: Trained Immunity Offers Novel Poultry Disease Prevention Strategies - PR Newswire - January 27th, 2025
- Scientists uncover how cancer cells hijack T-cells, making it harder for the body to fight back - Medical Xpress - January 27th, 2025
- MiNK Therapeutics Targets Immune Reconstitution to Combat - GlobeNewswire - January 27th, 2025
- Mitochondria may be a promising therapeutic target for inflammatory diseases - Medical Xpress - January 27th, 2025
- Explainer: What is Guillain-Barr Syndrome and how it affects the immune system - Mathrubhumi English - January 27th, 2025
- Yes, Some Vaccines Contain Aluminum. Thats a Good Thing. - The New York Times - January 27th, 2025
- You Are What You Eat? MD Breaks Down The Science Of The Gut Microbiome - mindbodygreen - January 27th, 2025
- Potential gamechanger: Researchers discover basis for immunotherapy-induced myocarditis - Healio - January 27th, 2025
- Ozempic and Wegovy may boost health, from addiction to dementia - BBC.com - January 27th, 2025
- Neutrophil diversity and function in health and disease - Nature.com - December 6th, 2024
- Harnessing the Power of the Immune System for Breast Cancer Treatment - Breast Cancer Research Foundation - December 6th, 2024
- Study Examines Neoantigen Landscapes and Their Role in Immunotherapy Efficacy - Consult QD - December 6th, 2024
- The 5 Best Teas to Support Your Immune System This Cold & Flu Season - EatingWell - December 6th, 2024
- Engineered immune cells may be able to tame inflammation - Medical Xpress - December 6th, 2024
- Hybrid model of tumor growth, angiogenesis and immune response yields strategies to improve antiangiogenic therapy - Nature.com - December 6th, 2024
- Opioids interfere with cancer immunotherapy, but another type of drug could help - Medical Xpress - December 6th, 2024
- RANKL cytokine restores thymus cells in old mice, reducing tumor growth and improving T cell immune response - Fierce Biotech - December 6th, 2024
- Predictive role of neutrophil percentage-to-albumin ratio, neutrophil-to-lymphocyte ratio, and systemic immune-inflammation index for mortality in... - December 6th, 2024
- Immuno-Oncology Strategic Industry Research Report 2023-2024 & 2030: Approval of Pembrolizumab (Keytruda) and Nivolumab (Opdivo), which Target... - December 6th, 2024
- Study cracks the cold case of immunotherapy resistance - News-Medical.Net - December 6th, 2024
- New immune therapy improves survival and reduces tumor burden in glioblastoma - News-Medical.Net - December 6th, 2024
- Identification of immune-related hub genes and potential molecular mechanisms involved in COVID-19 via integrated bioinformatics analysis - Nature.com - December 6th, 2024
- Immune Cell Breakthrough: Scientists Discover a Hidden Ally in the Fight Against Cancer - SciTechDaily - December 6th, 2024
- Rising temperatures impact the immune system of wild monkeys - Earth.com - December 6th, 2024
- Study declaring Alzheimer's to be a "brain disease" proven to be fabricated - Earth.com - December 6th, 2024
- Warming temperatures impact immune performance of wild monkeys, U-M study shows - University of Michigan News - December 6th, 2024
- New study explores heart risks of cancer immunotherapy - News-Medical.Net - December 6th, 2024
- 'Incredible' way to boost your immune system naturally and ward of colds and flu this winter - The Mirror - December 6th, 2024
- Tis the Season to Boost Your Immune System - Mix93.3 - December 6th, 2024